Avidity Biosciences, Inc.: auditor change — Avidity Biosciences appoints Deloitte as auditor; dismisses BDO effective after Q1 2025 filing

Avidity Biosciences, Inc.

Deloitte & Touche appointed as independent registered public accounting firm for FY2025, effective after Q1 2025 10-Q filing.
BDO dismissed on April 25, 2025; its 2023-2024 audit opinions were unqualified with no disagreements.
2023 material weakness in ITGC segregation of duties was fully remediated and BDO issued unqualified opinion on 2024 ICFR.
Company did not consult Deloitte on any accounting or audit matters prior to appointment.

item 4.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Avidity Biosciences, Inc. dismissed BDO USA, P.C. as its auditor.

Action: dismissal
Auditor: BDO USA, P.C.
Successor: Deloitte & Touche LLP

Exact text from the filing

the Audit Committee approved the dismissal of BDO USA, P.C. ("BDO") on April 25, 2025 as the Company's independent registered public accounting firm

View on SEC.gov

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Avidity Biosciences, Inc. engaged Deloitte & Touche LLP as its auditor.

Action: engagement
Auditor: Deloitte & Touche LLP

Exact text from the filing

the Audit Committee approved the appointment of Deloitte & Touche LLP ("Deloitte") as the Company's independent registered public accounting firm for the year ending December 31, 2025

View on SEC.gov

Browse all auditor changes →

Source: SEC EDGAR

accession 0001599901-25-000091

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.